Holen Sie sich die Stockscreener-App
4.24
7.61%
0.30
Vorhandelsmarkt:
4.24
Schlusskurs vom Vortag:
$3.94
Offen:
$4.24
24-Stunden-Volumen:
1.17M
Relative Volume:
1.93
Marktkapitalisierung:
$130.09M
Einnahmen:
$875.70K
Nettoeinkommen (Verlust:
$-39.57M
KGV:
-3.1588
EPS:
-1.3423
Netto-Cashflow:
$-33.65M
1W Leistung:
+8.72%
1M Leistung:
+16.16%
6M Leistung:
+78.53%
1J Leistung:
+36.33%
1-Tages-Spanne:
$4.13
$4.6499
1-Wochen-Bereich:
$3.69
$4.6499
52-Wochen-Spanne:
$1.90
$4.6499
Vistagen Therapeutics Inc Stock (VTGN) Company Profile
Firmenname
Vistagen Therapeutics Inc
Sektor
Branche
Telefon
650-577-3600
Adresse
343 ALLERTON AVENUE, SOUTH SAN FRANCISCO
Vergleichen Sie VTGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VTGN
Vistagen Therapeutics Inc
|
4.24 | 120.88M | 875.70K | -39.57M | -33.65M | -1.3423 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Vistagen Therapeutics Inc Stock (VTGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-12-07 | Hochstufung | Jefferies | Hold → Buy |
| 2023-08-07 | Hochstufung | Maxim Group | Hold → Buy |
| 2022-07-22 | Herabstufung | Jefferies | Buy → Hold |
| 2022-07-22 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-07-22 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-05-20 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-02-18 | Eingeleitet | Jefferies | Buy |
| 2021-01-04 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2018-06-27 | Eingeleitet | Maxim Group | Buy |
| 2018-02-08 | Bestätigt | Chardan Capital Markets | Buy |
| 2017-03-28 | Eingeleitet | Maxim Group | Buy |
Alle ansehen
Vistagen Therapeutics Inc Aktie (VTGN) Neueste Nachrichten
Is Vistagen Therapeutics Inc. stock attractive for income investorsTrade Risk Report & Smart Swing Trading Techniques - newser.com
Technical signs of recovery in Vistagen Therapeutics Inc.July 2025 Weekly Recap & Daily Profit Focused Stock Screening - newser.com
Using RSI to spot recovery in Vistagen Therapeutics Inc.July 2025 Sector Moves & Verified Swing Trading Watchlists - newser.com
How Vistagen Therapeutics Inc. stock compares to industry benchmarksJuly 2025 News Drivers & Stock Market Timing Techniques - newser.com
VistaGen stock rises after completing Phase 3 trial for anxiety drug By Investing.com - Investing.com Nigeria
VistaGen stock rises after completing Phase 3 trial for anxiety drug - Investing.com India
What dividend safety score for Vistagen Therapeutics Inc. stockMarket Risk Analysis & Short-Term Trading Alerts - newser.com
Is Vistagen Therapeutics Inc. a candidate for recovery play2025 Earnings Surprises & Low Drawdown Investment Strategies - newser.com
Can Vistagen Therapeutics Inc. stock deliver surprise earnings beat2025 Stock Rankings & Real-Time Volume Triggers - newser.com
Will Vistagen Therapeutics Inc. stock remain a Wall Street favoriteGap Down & Precise Buy Zone Tips - newser.com
Vistagen Completes PALISADE-3 Phase 3 Public Speaking Challenge Study for the Acute Treatment of Social Anxiety Disorder - Yahoo Finance
Vistagen Therapeutics Inc expected to post a loss of 48 cents a shareEarnings Preview - TradingView
Strategies to average down on Vistagen Therapeutics Inc.Risk Management & Safe Entry Zone Identification - newser.com
Is Vistagen Therapeutics Inc. stock reversal real or fake2025 Retail Activity & Real-Time Volume Triggers - newser.com
Will breakout in Vistagen Therapeutics Inc. lead to full recoveryEarnings Miss & High Return Trade Opportunity Guides - newser.com
Will Vistagen Therapeutics Inc. stock benefit from green energy trends2025 Earnings Impact & Accurate Intraday Trading Signals - newser.com
Is Vistagen Therapeutics Inc. stock a safe haven assetWeekly Stock Recap & High Accuracy Trade Alerts - newser.com
Will Vistagen Therapeutics Inc. stock gain from strong economy2025 Top Decliners & Fast Gain Swing Trade Alerts - newser.com
Should you hold or exit Vistagen Therapeutics Inc. nowWeekly Risk Summary & Weekly Watchlist for Hot Stocks - newser.com
Vistagen Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 Reactions & Intraday High Probability Setup Alerts - newser.com
Using fundamentals and technicals on Vistagen Therapeutics Inc.Earnings Recap Summary & Low Volatility Stock Recommendations - newser.com
Visualizing Vistagen Therapeutics Inc. stock with heatmapsOptions Play & Technical Pattern Alert System - newser.com
Published on: 2025-11-01 04:45:37 - newser.com
Combining machine learning predictions for Vistagen Therapeutics Inc.CEO Change & Reliable Price Action Trade Plans - newser.com
How to recover losses in Vistagen Therapeutics Inc. stockJuly 2025 Breakouts & Detailed Earnings Play Strategies - newser.com
How to escape a deep drawdown in Vistagen Therapeutics Inc.Day Trade & Low Risk Investment Opportunities - newser.com
VistaGen Therapeutics Appoints Paul R. Edick to Board - The Globe and Mail
Finanzdaten der Vistagen Therapeutics Inc-Aktie (VTGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):